Neoadjuvant treatment of a solitary melanoma brain metastasis with vemurafenib

Journal of Clinical Oncology

Volumn 31, Issue 3, 2013, Pages

  Kolar, Grant R ^a   Miller Thomas, Michelle M ^a   Schmidt, Robert E ^a   Simpson, Joseph R ^a   Rich, Keith M ^a   Linette, Gerald P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; DEXAMETHASONE; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; GLYCOPROTEIN GP 100; IPILIMUMAB; MELAN A; PROTEIN S 100; VEMURAFENIB; VIMENTIN;

ADULT; ANEMIA; ARTICLE; BRAIN METASTASIS; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CRANIOTOMY; DISEASE COURSE; FINE NEEDLE ASPIRATION BIOPSY; GENE MUTATION; HEMIPARESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE RESECTION; MALE; MELANOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STEREOTACTIC RADIOSURGERY; VISCERAL METASTASIS; WEIGHT REDUCTION; WHOLE BODY CT;

ADULT; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; COLONIC NEOPLASMS; HUMANS; INDOLES; MALE; MELANOMA; NEOADJUVANT THERAPY; SKIN NEOPLASMS; SULFONAMIDES;

EID: 84873378603     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.43.7061     Document Type: Article

References (22)

1. Salvati M, Frati A, D'Elia A, et al: Single brain metastases from melanoma: Remarks on a series of 84 patients. Neurosurg Rev 35:211-218, 2012
2. Lonser RR, Song DK, Klapper J, et al: Surgical management of melanoma brain metastases in patients treated with immunotherapy. J Neurosurg 115:30-36, 2011
3. Sampson JH, Carter JH Jr, Friedman AH, et al: Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 88:11-20, 1998 (Pubitemid 28018958)
4. Loeffler JS, Barker FG, Chapman PH: Role of radiosurgery in the management of central nervous system metastases. Cancer Chemother Pharmacol 43:S11-S14, 1999 (suppl) (Pubitemid 29244627)
5. Jenkinson MD, Haylock B, Shenoy A, et al: Management of cerebral metastasis: Evidence-based approach for surgery, stereotactic radiosurgery and radiotherapy. Eur J Cancer 47:649-655, 2011
6. Agarwala SS, Kirkwood JM, Gore M, et al: Temozolomide for the treatment of brain metastases associated with metastatic melanoma: A phase II study. J Clin Oncol 22:2101-2107, 2004 (Pubitemid 41095143)
7. Hodi FS, Oble DA, Drappatz J, et al: CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS. Nat Clin Pract Oncol 5:557-561, 2008
8. Schartz NE, Farges C, Madelaine I, et al: Complete regression of a previously untreated melanoma brain metastasis with ipilimumab. Melanoma Res 20:247-250, 2010
9. Margolin K, Ernstoff MS, Hamid O: Ipilimumab in patients with melanoma and brain metastases: An open-label, phase 2 trial. Lancet Oncol 13:459-465, 2012
10. Flaherty KT, Puzanov I, Kim KB, et al: Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 363:809-819, 2010
11. Wellcome Trust Sanger Institute: Catalogue of Somatic Mutations in Cancer (COSMIC database). http://www.sanger.ac.uk/genetics/CGP/cosmic/
12. Dummer R, Rinderknecht J, Goldinger S: An open-label pilot study of vemurafenib in previously treated metastatic melanoma patients with brain metastases. J Clin Oncol 29:537s, 2011 (abstr 8548)
13. Long GV, Trefzer U, Davies MA, et al: Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): A multicentre, open-label, phase 2 trial. Lancet Oncol 13:1087-1095, 2012
14. Rochet NM, Kottschade LA, Markovic SN: Vemurafenib for melanoma metastases to the brain. N Engl J Med 365:2439-2441, 2011
15. Strik HM, Stoll M, Meyermann R: Immune cell infiltration of intrinsic and metastatic intracranial tumours. Anticancer Res 24:37-42, 2004 (Pubitemid 38279686)
16. Jagannathan J, Bourne TD, Schlesinger D, et al: Clinical and pathologica characteristics of brain metastasis resected after failed radiosurgery. Neurosurgery 66:208-217, 2010
17. Wilmott JS, Long GV, Howle JR, et al: Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma. Clin Cancer Res 18:1386-1394, 2012
18. Hamid O, Schmidt H, Nissan A, et al: A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma. J Transl Med 9:204, 2011
19. Boni A, Cogdill AP, Dang P, et al: Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function. Cancer Res 70:5213-5219, 2010
20. Schindler G, Capper D, Meyer J, et al: Analysis of BRAF V600E mutation in 1, 320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma Acta Neuropathol 121:397-405, 2011
21. Du J, Miller AJ, Widlund HR, et al: MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma Am J Pathol 163:333-343, 2003
22. Jager E, Ringhoffer M, Karbach J, et al: Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: Evidence for immunoselection of antigen-loss variants in vivo. Int J Cancer 66:470-476, 1996 (Pubitemid 26178170)